Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (Ab125066)

推荐稀释比例

• IHC-P1/50 - 1/250 Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.
• WB1/1000 - 1/10000
• Flow Cyt (Intra)1/400

Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (ab125066) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB. Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (ab125066) was first used in a scientific publication in 2012 and has been cited over 567 times in peer reviewed journals. It's performance in Western Blot and IHC in mouse and human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (ab125066) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (ab125066) has been confirmed by Western Blot testing in Glutathione Peroxidase 4 knockout HeLa cells ( ab262509 ). Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (ab125066) has 12 independent reviews from customers. Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] (ab125066) specifically detects Glutathione Peroxidase 4 (UniProt ID: O70325; Molecular weight: 22kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPNCIR144 - ab219592. Antibody clone EPNCIR144 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647 ( ab314333, ab314334 ). Top cited antibody for this target with >1000 citations. Glutathione peroxidase 4 is a master regulator of ferroptosis and lipid peroxidation. This antibody is crucial in cancer research, particularly in understanding GPX4's role in cell death and antioxidant defence and is widely used in studies of reactive oxygen species (ROS) and GPX4 inhibitors for therapeutic applications. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.